Preoperative [18F]Fluorodeoxyglucose Positron Emission Tomography Standardized Uptake Value of Neck Lymph Nodes Predicts Neck Cancer Control and Survival Rates in Patients With Oral Cavity Squamous Cell Carcinoma and Pathologically Positive Lymph Nodes

International Journal of Radiation Oncology Biology Physics

Volumn 74, Issue 4, 2009, Pages 1054-1061

  Liao, Chun Ta ^a   Chang, Joseph Tung Chieh ^a   Wang, Hung Ming ^a   Ng, Shu Hang ^a   Hsueh, Chuen ^a   Lee, Li Yu ^a   Lin, Chih Hung ^a   Chen, I How ^a   Huang, Shiang Fu ^a   Cheng, Ann Joy ^a   Yen, Tzu Chen ^a  

^a CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

18F FDG PET; Prediction; Squamous cell carcinoma of oral cavity; Survival

Indexed keywords

18-F-FLUORODEOXYGLUCOSE; 18F-FDG PET; ADJUVANT THERAPY; COX REGRESSION ANALYSIS; CUT-OFF VALUE; DISEASE-FREE SURVIVAL; DISEASE-SPECIFIC SURVIVALS; INDEPENDENT PREDICTORS; LOCOREGIONAL CONTROL; LYMPH NODE; MULTI VARIATE ANALYSIS; NECK CANCER; ORAL CAVITY; OVERALL SURVIVAL; POSITIVE LYMPH NODES; PREDICTION; PROSPECTIVE STUDY; RADICAL SURGERY; RISK FACTORS; SQUAMOUS CELL CARCINOMA; SQUAMOUS CELL CARCINOMA OF ORAL CAVITY; STANDARDIZED UPTAKE VALUES; SURVIVAL; SURVIVAL RATE;

BODY FLUIDS; DECISION MAKING; MULTIVARIANT ANALYSIS; POSITRON ANNIHILATION SPECTROSCOPY; POSITRONS; REGRESSION ANALYSIS; SURGERY;

POSITRON EMISSION TOMOGRAPHY;

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CERVICAL LYMPH NODE; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MOUTH CARCINOMA; NECK CANCER; NECK DISSECTION; OVERALL SURVIVAL; POSITRON EMISSION TOMOGRAPHY; PREOPERATIVE RADIOTHERAPY; PRIORITY JOURNAL; PROGNOSIS; SQUAMOUS CELL CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MOUTH NEOPLASMS; NECK; POSITRON-EMISSION TOMOGRAPHY; PROGNOSIS; PROSPECTIVE STUDIES; RADIOPHARMACEUTICALS; REGRESSION ANALYSIS; SURVIVAL RATE;

EID: 67649616515     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2008.09.045     Document Type: Article

References (39)

1. Liao C.T., Chang J.T., Wang H.M., et al. Analysis of risk factors predictive of local tumor control in oral cavity cancer. Ann Surg Oncol 15 (2008) 915-922
2. Liao C.T., Wang H.M., Ng S.H., et al. Good tumor control and survivals of squamous cell carcinoma of buccal mucosa treated with radical surgery with or without neck dissection in Taiwan. Oral Oncol 42 (2006) 800-809
3. Liao C.T., Wang H.M., Chang J.T., et al. Analysis of risk factors for distant metastases in squamous cell carcinoma of the oral cavity. Cancer 110 (2007) 1501-1508
4. Liao C.T., Chang J.T., Wang H.M., et al. Surgical outcome of T4a and resected T4b oral cavity cancer. Cancer 107 (2006) 337-344
5. Liao C.T., Chang J.T., Wang H.M., et al. Salvage therapy in relapsed squamous cell carcinoma of the oral cavity: How and when?. Cancer 112 (2008) 94-103
6. Liao C.T., Chang J.T., Wang H.M., et al. Survival in squamous cell carcinoma of the oral cavity: Differences between pT4N0 and other stage IVA categories. Cancer 110 (2007) 564-571
7. Liao C.T., Wang H.M., Hsieh L.L., et al. Higher distant failure in young age tongue cancer patients. Oral Oncol 42 (2006) 718-725
8. Liao C.T., Ng S.H., Chang J.T., et al. T4b oral cavity cancer below the mandibular notch is resectable with a favorable outcome. Oral Oncol 43 (2007) 570-579
9. Ng S.H., Yen T.C., Chang J.T., et al. Prospective study of [18F]fluorodeoxyglucose positron emission tomography and computed tomography and magnetic resonance imaging in oral cavity squamous cell carcinoma with palpably negative neck. J Clin Oncol 24 (2006) 4371-4376
10. Wensing B.M., Vogel W.V., Marres H.A., et al. FDG-PET in the clinically negative neck in oral squamous cell carcinoma. Laryngoscope 116 (2006) 809-813
11. Schoder H., Carlson D.L., Kraus D.H., et al. 18F-FDG PET/CT for detecting nodal metastases in patients with oral cancer staged N0 by clinical examination and CT/MRI. J Nucl Med 47 (2006) 755-762
12. Ng S.H., Yen T.C., Liao C.T., et al. 18F-FDG PET and CT/MRI in oral cavity squamous cell carcinoma: A prospective study of 124 patients with histologic correlation. J Nucl Med 46 (2005) 1136-1143
13. Yen T.C., Chang J.T., Ng S.H., et al. Staging of untreated squamous cell carcinoma of buccal mucosa with 18F-FDG PET: Comparison with head and neck CT/MRI and histopathology. J Nucl Med 46 (2005) 775-781
14. Stoeckli S.J., Steinert H., Pfaltz M., and Schmid S. Is there a role for positron emission tomography with 18F-fluorodeoxyglucose in the initial staging of nodal negative oral and oropharyngeal squamous cell carcinoma. Head Neck 24 (2002) 345-349
15. Nakasone Y., Inoue T., Oriuchi N., et al. The role of whole-body FDG-PET in preoperative assessment of tumor staging in oral cancers. Ann Nucl Med 15 (2001) 505-512
16. Stuckensen T., Kovacs A.F., Adams S., and Baum R.P. Staging of the neck in patients with oral cavity squamous cell carcinomas: A prospective comparison of PET, ultrasound, CT and MRI. J Craniomaxillofac Surg 28 (2000) 319-324
17. Myers L.L., and Wax M.K. Positron emission tomography in the evaluation of the negative neck in patients with oral cavity cancer. J Otolaryngol 27 (1998) 342-347
18. Braams J.W., Pruim J., Nikkels P.G., Roodenburg J.L., Vaalburg W., and Vermey A. Nodal spread of squamous cell carcinoma of the oral cavity detected with PET-tyrosine, MRI and CT. J Nucl Med 37 (1996) 897-901
19. Kovacs A.F., Dobert N., Gaa J., Menzel C., and Bitter K. Positron emission tomography in combination with sentinel node biopsy reduces the rate of elective neck dissections in the treatment of oral and oropharyngeal cancer. J Clin Oncol 22 (2004) 3973-3980
20. Kunkel M., Helisch A., Reichert T.E., et al. Clinical and prognostic value of [(18)F]FDG-PET for surveillance of oral squamous cell carcinoma after surgical salvage therapy. Oral Oncol 42 (2006) 297-305
21. Kunkel M., Forster G.J., Reichert T.E., et al. Detection of recurrent oral squamous cell carcinoma by [18F]-2-fluorodeoxyglucose-positron emission tomography: Implications for prognosis and patient management. Cancer 98 (2003) 2257-2265
22. Kunkel M., Forster G.J., Reichert T.E., et al. Radiation response non-invasively imaged by [18F]FDG-PET predicts local tumor control and survival in advanced oral squamous cell carcinoma. Oral Oncol 39 (2003) 170-177
23. Wong R.J., Lin D.T., Schoder H., et al. Diagnostic and prognostic value of [(18)F]fluorodeoxyglucose positron emission tomography for recurrent head and neck squamous cell carcinoma. J Clin Oncol 20 (2002) 4199-4208
24. McCollum A.D., Burrell S.C., Haddad R.I., et al. Positron emission tomography with 18F-fluorodeoxyglucose to predict pathologic response after induction chemotherapy and definitive chemoradiotherapy in head and neck cancer. Head Neck 26 (2004) 890-896
25. Yao M., Graham M.M., Hoffman H.T., et al. The role of post-radiation therapy FDG PET in prediction of necessity for post-radiation therapy neck dissection in locally advanced head-and-neck squamous cell carcinoma. Int J Radiat Oncol Biol Phys 59 (2004) 1001-1010
26. Lowe V.J., Dunphy F.R., Varvares M., et al. Evaluation of chemotherapy response in patients with advanced head and neck cancer using [F-18]fluorodeoxyglucose positron emission tomography. Head Neck 19 (1997) 666-674
27. Allal A.S., Dulguerov P., Allaoua M., et al. Standardized uptake value of 2-[(18)F] fluoro-2-deoxy-D-glucose in predicting outcome in head and neck carcinomas treated by radiotherapy with or without chemotherapy. J Clin Oncol 20 (2002) 1398-1404
28. Allal A.S., Slosman D.O., Kebdani T., Allaoua M., Lehmann W., and Dulguerov P. Prediction of outcome in head-and-neck cancer patients using the standardized uptake value of 2-[18F]fluoro-2-deoxy-D-glucose. Int J Radiat Oncol Biol Phys 59 (2004) 1295-1300
29. Minn H., Lapela M., Klemi P.J., et al. Prediction of survival with fluorine-18-fluoro-deoxyglucose and PET in head and neck cancer. J Nucl Med 38 (1997) 1907-1911
30. Schwartz D.L., Rajendran J., Yueh B., et al. FDG-PET prediction of head and neck squamous cell cancer outcomes. Arch Otolaryngol Head Neck Surg 130 (2004) 1361-1367
31. Halfpenny W., Hain S.F., Biassoni L., Maisey M.N., Sherman J.A., and McGurk M.F.D.G.-P.E.T. A possible prognostic factor in head and neck cancer. Br J Cancer 86 (2002) 512-516
32. Kim S.Y., Roh J.L., Kim M.R., et al. Use of 18F-FDG PET for primary treatment strategy in patients with squamous cell carcinoma of the oropharynx. J Nucl Med 48 (2007) 752-757
33. Fleming I.D., Cooper J.S., Henson D.E., et al. AJCC Cancer Staging Manual. 5th ed. (1997), Lippincott-Raven, Philadelphia
34. Greene F.L., Page D.L., Fleming I.D., et al. AJCC Cancer Staging Manual. 6th ed. (2002), Springer-Verlag, New York
35. Yen T.C., Ng K.K., Ma S.Y., et al. Value of dual-phase 2-fluoro-2-deoxy-d-glucose positron emission tomography in cervical cancer. J Clin Oncol 21 (2003) 3651-3658
36. Bachaud J.M., Cohen-Jonathan E., Alzieu C., David J.M., Serrano E., and Daly-Schveitzer N. Combined postoperative radiotherapy and weekly cisplatin infusion for locally advanced head and neck carcinoma: Final report of a randomized trial. Int J Radiat Oncol Biol Phys 36 (1996) 999-1004
37. Wang H.M., Wang C.S., Chen J.S., et al. Cisplatin, tegafur, and leucovorin: A moderately effective and minimally toxic outpatient neoadjuvant chemotherapy for locally advanced squamous cell carcinoma of the head and neck. Cancer 94 (2002) 2989-2995
38. Bernier J., Domenge C., Ozsahin M., et al. Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. N Engl J Med 350 (2004) 1945-1952
39. Cooper J.S., Pajak T.F., Forastiere A.A., et al. Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. N Engl J Med 350 (2004) 1937-1944